HSV-2 Infection: Clinical Trials

9 trials for HSV-2 Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 4 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Phase 22Not yet recruiting 1, Terminated 1

Follow HSV-2 Infection: new trials by email Literature Review of HSV-2 Infection trials Research Report on HSV-2 Infection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Compare GS-1179 Versus Valacyclovir in HSV-2 Seropositive Participants With Recurrent Genital Herpes
GS-1179, GS-1179 PTM, Valacyclovir - HSV-2 Infection
Phase 2Not yet recruitingGilead Sciences3002026-11-012026-11-03
NOWDx Test for the Diagnosis of Herpes Simplex Virus Type 2
Diagnostic Test: NOWDx HSV-2 Test - HSV-2 Infection, Herpes Simplex Virus Infection
WithdrawnNOWDiagnostics, Inc.2023-03-012024-02-29
Immunogenetic Modulators of Mucosal Protection From HIV-1
HIV Infections, HSV-2 Infection
CompletedUniversity of Washington8122018-09-272020-11-03
Cash Transfer to Adolescent Girls and Young Women to Reduce Sexual Risk Behavior - an Impact Evaluation
Cash Transfer - HIV/AIDS, HSV-2 Infection
Not applicableUnknownNational Institute for Medical Research, Tanzania31202017-10-302018-07-26
Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection
GEN-003, Matrix-M2, 0.9% normal saline - Genital Herpes, HSV-2 Infection
Phase 2TerminatedGenocea Biosciences, Inc.332017-05-242019-02-19
The VIBLOK SAfety and perFormancE Trial
VIBLOK barrier cream - HSV-2 Infection, Genital Herpes
Not applicableCompletedCLJI Worldwide822017-03-272020-02-13
Comparative Effectiveness of Treatment Options for Genital Herpes Infection to Reduce Adverse Pregnancy Outcomes
HSV-2 Infection, PreTerm Birth
CompletedKaiser Permanente891322017-03-142021-09-17
Impact Evaluation of a School-Based Sexuality and HIV Prevention Education Activity in South Africa
School-based sexuality and HIV prevention scripted lesson plans - HSV-2 Infection, HIV Infections
Not applicableCompletedUniversity of North Carolina, Chapel Hill230612016-08-082019-12-19
The Impact of VCT and Condom Distribution as HIV Prevention Strategies Among Youth in Kenya
Voluntary Counseling and Testing for HIV (VCT), Condoms - HIV/AIDS, HSV-2 Infection
Not applicableCompletedAbdul Latif Jameel Poverty Action Lab106462009-02-012020-01-14

Narrower conditions

Herpes Genitalis (4)  ·  Acquired Immunodeficiency Syndrome (2)  ·  HIV Infections (2)  ·  Herpes Simplex (2)  ·  Pregnancy Complications (1)  ·  Premature Birth (1)

Broader conditions

Urogenital Diseases (8)  ·  Communicable Diseases (7)  ·  Genital Diseases (7)  ·  Infections (7)  ·  Sexually Transmitted Diseases (7)  ·  Sexually Transmitted Diseases, Viral (7)  ·  Virus Diseases (7)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Blood-Borne Infections (4)  ·  DNA Virus Infections (4)  ·  Female Urogenital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Diseases, Male (4)  ·  Herpesviridae Infections (4)  ·  Immune System Diseases (4)

Interventions

Adjuvants, Pharmaceutic (1)  ·  Condoms (1)  ·  M2 protein, Influenza A virus (1)  ·  Saline Solution (1)  ·  Seroconversion (1)  ·  Valacyclovir (1)

Sponsors

Abdul Latif Jameel Poverty Action Lab (1)  ·  CLJI Worldwide (1)  ·  Genocea Biosciences, Inc. (1)  ·  Gilead Sciences (1)  ·  Kaiser Permanente (1)  ·  NOWDiagnostics, Inc. (1)  ·  National Institute for Medical Research, Tanzania (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Washington (1)

Countries

United States (3)  ·  Kenya (1)  ·  Netherlands (1)  ·  South Africa (1)  ·  Tanzania (1)

Top investigators

Beth Cobb (1)  ·  De-Kun Li, MD (1)  ·  Esther Duflo (1)  ·  Ilene Speizer, PhD (1)  ·  Jairam Lingappa, MD, PhD (1)  ·  Mwita Wambura, PhD (1)  ·  Pascaline Dupas (1)  ·  Vandana Sharma (1)

Results publications

PMID 31361767, PMID 31593577, PMID 31859686, PMID 33054742, PMID 33362883, PMID 36121686, PMID 40131862

NIH funding

R01AI129715 (1), R01AI131914 (1), R01AI141435 (1)